ShreeOswal Seeds And Chemicals Limited
ShreeOswal Seeds And Chemicals Limited (OSWALSEEDS) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
oswalseeds.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-02
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 66 Cr | 77 Cr | 43 Cr | 77 Cr | 68 Cr | 75 Cr | 26 Cr | 98 Cr | 39 Cr | 55 Cr | 56 Cr | 117 Cr |
| Operating expenses (approx.) | 63 Cr | 78 Cr | 48 Cr | 79 Cr | 66 Cr | 67 Cr | 24 Cr | 87 Cr | 43 Cr | 52 Cr | 52 Cr | 99 Cr |
| EBITDA | 2 Cr | -1 Cr | -5 Cr | -2 Cr | 2 Cr | 8 Cr | 2 Cr | 11 Cr | -4 Cr | 3 Cr | 4 Cr | 18 Cr |
| OPM % | 3.7% | -1.5% | -10.7% | -2.6% | 2.3% | 10.8% | 7.5% | 11.5% | -8.9% | 5.1% | 7.2% | 15.7% |
| Other income | 0.01 Cr | 0.0025 Cr | 0.09 Cr | 0.0063 Cr | 0.0028 Cr | 0.05 Cr | 0.24 Cr | 0.07 Cr | 0.0041 Cr | 0.01 Cr | 0.28 Cr | 0.0069 Cr |
| Interest | 1 Cr | 2 Cr | 2 Cr | 1 Cr | 0.95 Cr | 0.75 Cr | 1 Cr | 1 Cr | 0.94 Cr | 1 Cr | 1 Cr | 1 Cr |
| Depreciation | 0.14 Cr | 0.17 Cr | 0.08 Cr | 0.13 Cr | 0.13 Cr | 0.12 Cr | 0.12 Cr | 0.15 Cr | 0.19 Cr | 0.19 Cr | 0.18 Cr | 0.17 Cr |
| Profit before tax | 0.89 Cr | -3 Cr | -6 Cr | -4 Cr | 0.46 Cr | 7 Cr | 0.94 Cr | 10 Cr | -5 Cr | 1 Cr | 3 Cr | 17 Cr |
| Tax % | 27.8% | -14.9% | 43.3% | 24.4% | 29.4% | 26.5% | 41.1% | 27.9% | 30.8% | 27.9% | 21.9% | 27.4% |
| Net profit | 0.64 Cr | -3 Cr | -4 Cr | -3 Cr | 0.32 Cr | 5 Cr | 0.55 Cr | 7 Cr | -3 Cr | 1 Cr | 2 Cr | 12 Cr |
| EPS (₹) | ₹0.15 | ₹-0.44 | ₹-0.38 | ₹-0.30 | ₹0.04 | ₹0.59 | ₹0.06 | ₹0.80 | ₹-0.35 | ₹0.11 | ₹0.23 | ₹1.34 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|
| Sales | 272 Cr | 269 Cr | 246 Cr | 248 Cr | Sign in for TTM |
| Operating expenses (approx.) | 260 Cr | 268 Cr | 236 Cr | 234 Cr | Sign in for TTM |
| EBITDA | 12 Cr | 1 Cr | 10 Cr | 15 Cr | Sign in for TTM |
| OPM % | 4.4% | 0.4% | 3.9% | 5.9% | Sign in for TTM |
| Other income | 0.12 Cr | 0.11 Cr | 0.30 Cr | 0.37 Cr | Sign in for TTM |
| Interest | 4 Cr | 6 Cr | 4 Cr | 5 Cr | Sign in for TTM |
| Depreciation | 0.43 Cr | 0.52 Cr | 0.50 Cr | 0.71 Cr | Sign in for TTM |
| Profit before tax | 8 Cr | -5 Cr | 5 Cr | 10 Cr | Sign in for TTM |
| Tax % | 27.7% | 22.6% | 30.9% | 24.8% | Sign in for TTM |
| Net profit | 6 Cr | -4 Cr | 4 Cr | 7 Cr | Sign in for TTM |
| EPS (₹) | ₹3.74 | ₹-0.45 | ₹0.39 | ₹0.79 | Sign in for TTM |
| Dividend payout % | 0.0% | — | 0.0% | 0.0% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Equity capital | 15 Cr | 18 Cr | 18 Cr | 18 Cr |
| Reserves | 29 Cr | 22 Cr | 25 Cr | 33 Cr |
| Borrowings | 41 Cr | 64 Cr | 42 Cr | 62 Cr |
| Other liabilities | 43 Cr | 20 Cr | 19 Cr | 28 Cr |
| Total liabilities | 128 Cr | 124 Cr | 105 Cr | 141 Cr |
| Fixed assets (net) | 4 Cr | 7 Cr | 6 Cr | 8 Cr |
| CWIP | 1 Cr | 2 Cr | 2 Cr | 0.85 Cr |
| Investments | 0.0063 Cr | 0.01 Cr | 0.0073 Cr | 0.0092 Cr |
| Loans & advances | 0 Cr | 0 Cr | 0.01 Cr | 0 Cr |
| Inventories | 103 Cr | 83 Cr | 65 Cr | 82 Cr |
| Trade receivables | 8 Cr | 17 Cr | 13 Cr | 35 Cr |
| Cash & bank | 5 Cr | 3 Cr | 0.24 Cr | 1 Cr |
| Other assets | 7 Cr | 12 Cr | 18 Cr | 13 Cr |
| Total assets | 128 Cr | 124 Cr | 105 Cr | 141 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Cash from operating activity | 12 Cr | -15 Cr | 24 Cr | -14 Cr |
| Cash from investing | -2 Cr | -3 Cr | -0.77 Cr | -0.72 Cr |
| Cash from financing | -6 Cr | 17 Cr | -26 Cr | 15 Cr |
| Net cash flow | 3 Cr | -2 Cr | -3 Cr | 1 Cr |
| Free cash flow (OCF − Capex) | 10 Cr | -18 Cr | 24 Cr | -14 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| ROCE % | 13.6% | 0.6% | 10.9% | 12.6% |
| ROE % | 12.9% | -10.3% | 8.1% | 14.2% |
| Debtor days | 11 | 24 | 19 | 51 |
| Inventory days | 126 | 116 | 129 | 123 |
| Days payable | 3 | 4 | 8 | 8 |
| Cash conversion cycle | 134 | 135 | 139 | 165 |
| Debt / equity | 0.92 | 1.59 | 0.96 | 1.21 |
| Current ratio | 1.49 | 1.35 | 1.56 | 1.49 |
| Net debt / EBITDA | 3.03 | 60.50 | 4.35 | 4.17 |